Age-related changes in the hemostatic system (original) (raw)
References
Aillaud MF, Pignol F, Alessi MC, Harle JR, Escande M, Mongin M, Juhan-Vague I, Increase in plasma concentration of plasminogen activator inhibitor, fibrinogen, von Willebrand factor, factor VIII: C and in erythrocyte sedimentation rate with age. Thromb Haemost 55:330, 1986 PubMedCAS Google Scholar
Balleisen L, Bailey J, Epping PH, Schulte H, Loo J van de, Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population. I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause. Thromb Haemost 54:475, 1985 PubMedCAS Google Scholar
Bauer KA, Weiss LM, Sparrow D, Vokonas PS, Rosenberg RD, Aging-associated changes in indices of thrombin generation and protein C activation in humans. J Clin Invest 80:1527, 1987 PubMedCAS Google Scholar
Bauer KA, Kass BL, Cate HC, Hawiger JJ, Rosenberg RD, Factor IX is activated in vivo by the tissue factor mechanism. Blood 76:731, 1990 PubMedCAS Google Scholar
Ginsberg BH, Jabour J, Spector AA, Effect of alterations in membrane lipid unsaturation on the properties of the insulin receptor of Ehrlich ascites cells. Biochim Biophys Acta 690:157, 1982 ArticlePubMedCAS Google Scholar
Hatake H, Kakishita E, Wakabayashi I, Sakiyama N, Hishida S, Effect of aging on endothelium-dependent vascular relaxation of isolated human basilar artery to thrombin and bradykinin. Stroke 21:1039, 1990 PubMedCAS Google Scholar
Kannel WB, Wolf PA, Castelli WP, D’Agostino RB, Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 258:1183, 1987 ArticlePubMedCAS Google Scholar
Ludlam CA, Evidence for the platelet specificity of B-thromboglobulin and studies on its plasma concentration in healthy individuals. Br J Haematol 41:271, 1979 PubMedCAS Google Scholar
Mannucci PM, Vigano’ S, Deficiencies of protein C, an inhibitor of blood coagulation. Lancet II:463, 1982 Article Google Scholar
McMurchie EJ, Raison JK, Membrane lipid fluidity and its effect on the activation energy of membrane-associated enzymes. Biochim Biophys Acta 554:364, 1979 ArticlePubMedCAS Google Scholar
Meade TW, North WRS, Chakrabarti R, Haines AP, Stirling Y, Population-based distributions of hemostatic variables. Br Med Bull 33:283, 1977 PubMedCAS Google Scholar
Meade TW, Chakrabarti R, Haines AP, North WRS, Stirling Y, Characteristic affecting fibrinolytic activity and plasma fibrinogen concentration. BMJ 1:153, 1979 ArticlePubMedCAS Google Scholar
Meade TW, Chakrabarti R, Haines AP, North Y, Thompson SG, Brozovic M, Haemostatic function and cardiovascular death: early results of a prospective study. Lancet I:1050, 1980 Article Google Scholar
Meade TW, Vickers MV, Thompson SG, Stirling Y, Haines AP, Miller AJ, Epidemiological characteristics of platelet aggregability. BMJ 290:428, 1985 PubMedCAS Google Scholar
Mehta J, Mehta P, Lawson D, Saldeen T, Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations. J Am Coll Cardiol 9:263, 1987 ArticlePubMedCAS Google Scholar
Modesti PA, Fortini A, Abbate R, Gensini GF, Age-related changes of platelet prostacyclin receptors in humans. Eur J Clin Invest 15:204, 1985 ArticlePubMedCAS Google Scholar
Pace-Asciak C, Wolfe LS, Inhibition of prostaglandin synthesis by oleic, linoleic and linolenic acids. Biochim Biophys Acta 152:784, 1968 PubMedCAS Google Scholar
Prisco D, Rogasi PG, Matucci M, Paniccia R, Abbate R, Gensini GF, Neri Serneri GG, Age related changes in platelet lipid composition. Thromb Res 44:427, 1986 ArticlePubMedCAS Google Scholar
Reilly JAG, FitzGerald GA, Eicosanoid biosynthesis and platelet function with advancing age. Thromb Res 41:545, 1986 ArticlePubMedCAS Google Scholar
Renaud S, Kuba K, Goulet C, Lemire Y, Allard C, Relationship between fatty acid composition of platelets and platelet aggregation in rat and in man. Circ Res 26:553, 1970 PubMedCAS Google Scholar
Stegnar M, Keber D, Pentek M, Vene N, Kluft C, Age and sex differences in resting and postocclusion values of tissue plasminogen activator in a healthy population. Fibrinolysis 2 [Suppl 2]: 121, 1988 CAS Google Scholar
Stone MC, Thorpe JM, Plasma fibrinoge—a major coronary risk factor. J R Coll Gen Pract 35:565, 1985 PubMedCAS Google Scholar
Stratton JR, Chandler WL, Schwartz RS, et al., Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults. Circulation 83:1692, 1991 PubMedCAS Google Scholar
Stuart MJ, Gerrard JM, White JG, Effect of cholesterol on production of thromboxane B2 by platelets in vitro. N Engl J Med 302:6, 1980 ArticlePubMedCAS Google Scholar
Sundell IB, Nilsson TK, Ranby M, Hallmans G, Hellsten G, Fibrinolytic variables are related to age, sex, blood pressure, and body build measurements: a cross-sectional study in Norsjo, Sweden. J Clin Epidemiol 42:719, 1989 ArticlePubMedCAS Google Scholar
Warr TA, Warn-Cramer BJ, Mohan Rao LV, Rapaport SI, Human plasma extrinsic pathway inhibitor activity. I. Standardization of assay and evaluation of physiologic variables. Blood 74:201, 1989 PubMedCAS Google Scholar
Wilhelmsen L, Svardsudd K, Korsan-Bengsten K, Larsson B, Welin L, Tibblin G, Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 311:501, 1984 ArticlePubMedCAS Google Scholar